Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Huahang Lin"'
Autor:
Jian Wang, Jiajia Du, Xiangmeng Luo, Linjie Guo, Yixin Liu, Jianfeng Zhou, Yang Zou, Zhenghao Lu, Xiangyu Pan, Xuelan Chen, Ailing Zhong, Xudong Wan, Lu Wang, Hongyu Liu, Siqi Dai, Shiyu Zhang, Xingyu Xiong, Ping Tan, Manli Wang, Baohong Wu, Qi Zhang, Yingjie Wang, Mengsha Zhang, Runda Lu, Huahang Lin, Yuan Li, Yaxin Li, Zongkai Han, Longqi Chen, Bing Hu, Yu Liu, Feifei Na, Chong Chen
Publikováno v:
Cell Reports, Vol 43, Iss 11, Pp 114952- (2024)
Summary: Genomics studies have detected numerous genetic alterations in esophageal squamous cell carcinoma (ESCC). However, the functions of these mutations largely remain elusive, partially due to a lack of feasible animal models. Here, we report a
Externí odkaz:
https://doaj.org/article/3a9c8ad8c8d84646a7c4335189cfc6cb
Autor:
Zetao Liu, Zhiyu Peng, Huahang Lin, Ke Zhou, Linchuan Liang, Jie Cao, Zhaokang Huang, Jiandong Mei
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-8 (2024)
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a chronic fibrotic interstitial lung disease characterized by progressive dyspnea and decreased lung function, yet its exact etiology remains unclear. It is of great significance to discover
Externí odkaz:
https://doaj.org/article/2c6a60b80d8b420f9e3da5d2676486ae
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundTo date, there is no treatment consensus on mucosa-associated lymphoid tissue (MALT) derived primary pulmonary lymphoma (PPL).MethodsWe identified patients with early-stage MALT-type PPL from the National Cancer Institute’s Surveillance,
Externí odkaz:
https://doaj.org/article/b2771838f3104d60b97decdb1aa450da
Autor:
Ke Zhou, Jie Cao, Huahang Lin, Linchuan Liang, Zhongzhong Shen, Lei Wang, Zhiyu Peng, Jiandong Mei
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundIt remains controversial whether the platelet to lymphocyte ratio (PLR) serves as a potential indicator for the efficacy of immunotherapy in advanced lung cancer. This meta-analysis aimed to address this concern.MethodsUp to March 2022, we
Externí odkaz:
https://doaj.org/article/3d93594624e34bef8b70039b616920a0
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundRoutine administration of adjuvant chemotherapy for stage IB non-small cell lung cancer (NSCLC) remains controversial. To our knowledge, no available studies have assessed the outcomes of chemotherapy in patients with stage IB NSCLC who had
Externí odkaz:
https://doaj.org/article/c14fa6f42f874d078d4091edc8ca8a68
Publikováno v:
World Journal of Surgical Oncology, Vol 19, Iss 1, Pp 1-13 (2021)
Abstract Objective To investigate the predictive value of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer (NSCLC) patients treated with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). Methods We con
Externí odkaz:
https://doaj.org/article/222a716fac8d41f6a3d10ee8163812d7
Autor:
Huahang Lin, Zhiyu Peng, Ke Zhou, Linchuan Liang, Jie Cao, Zhaokang Huang, Lonqi Chen, Jiandong Mei
Publikováno v:
International Journal of Surgery; Feb2024, Vol. 110 Issue 2, p1159-1171, 13p
Additional file 1: Table S1. Checklist of the PRISMA extension for meta-analysis. Table S2. Literature search criteria.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c3ecdf43a129469b8bf556c0c5c0250
